Ascendis Pharma A/S Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 250.7M | 245.2M | 213.6M | 158.0M | 101.0M | 173.9M | 57.8M | 36.0M |
| Cost of Goods Sold | 21.6M | 27.2M | 22.4M | 31.4M | 17.5M | 14.0M | 11.2M | 11.5M |
| Gross Profit | 229.0M | 218.0M | 191.3M | 126.6M | 83.4M | 159.9M | 46.6M | 24.5M |
| R&D Expenses | 57.6M | 75.0M | 66.9M | 72.0M | 86.6M | 79.3M | 73.5M | 83.5M |
| Operating Expenses | 203.8M | 208.2M | 180.3M | 179.5M | 187.6M | 159.5M | 143.4M | 157.8M |
| Operating Income | 25.2M | 9.8M | 11.0M | -53.0M | -104.2M | 383K | -96.7M | -133.3M |
| Other Income / Gains | -74.2M | -36.3M | -68.4M | 17.9M | 10.6M | -37.8M | -1.4M | 24.1M |
| Net Income | 639.7M | -33.2M | -61.0M | -38.9M | -94.6M | -38.5M | -99.2M | -109.4M |
| EPS (Diluted) | 10.37 | -0.54 | -1.00 | -0.64 | -1.58 | -0.64 | -1.69 | -1.91 |
| Reported Currency | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Gross Profit Ratio | 0.914 | 0.889 | 0.895 | 0.801 | 0.826 | 0.919 | 0.806 | 0.682 |
| General And Administrative Expenses | 0 | 0 | 111.7M | 105.7M | 95.6M | 78.8M | 68.1M | 72.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.0M |
| Selling General And Administrative Expenses | 146.2M | 133.2M | 111.7M | 105.7M | 95.6M | 78.8M | 68.1M | 74.3M |
| Other Expenses | 0 | 0 | 1.7M | 1.9M | 5.4M | 1.4M | 1.7M | 0 |
| Cost And Expenses | 225.4M | 235.4M | 202.6M | 211.0M | 205.2M | 173.5M | 154.6M | 169.3M |
| Interest Income | 4.6M | 23.8M | 3.3M | 55.1M | 28.9M | -66.5M | 28.3M | 49.1M |
| Interest Expense | 68.4M | 61.4M | 19.7M | 33.0M | 44.8M | -56.6M | 25.3M | 19.6M |
| Depreciation And Amortization | 4.3M | 4.8M | 4.0M | 4.3M | 4.5M | 4.5M | 1.7M | 2.0M |
| Ebitda | 29.5M | 14.6M | -53.4M | 2.3M | -44.2M | -37.9M | -71.1M | -87.5M |
| Ebitdaratio | 0.118 | 0.059 | -0.25 | 0.015 | -0.438 | -0.218 | -1.23 | -2.431 |
| Operating Income Ratio | 0.101 | 0.04 | 0.051 | -0.335 | -1.032 | 0.002 | -1.673 | -3.702 |
| Income Before Tax | -49.0M | -26.5M | -57.4M | -35.0M | -93.6M | -37.4M | -98.2M | -109.2M |
| Income Before Tax Ratio | -0.195 | -0.108 | -0.269 | -0.222 | -0.927 | -0.215 | -1.698 | -3.032 |
| Income Tax Expense | -688.7M | 6.8M | 3.6M | 3.8M | 1.1M | 1.1M | 1.0M | 229K |
| Net Income Ratio | 2.552 | -0.136 | -0.285 | -0.246 | -0.937 | -0.221 | -1.715 | -3.039 |
| Epsdiluted | 9.91 | -0.54 | -1.00 | -0.82 | -1.58 | -0.64 | -1.69 | -1.91 |
| Weighted Average Shs Out | 61.7M | 61.4M | 61.0M | 60.5M | 60.0M | 59.8M | 58.6M | 57.3M |
| Weighted Average Shs Out Dil | 64.5M | 61.4M | 61.0M | 63.9M | 60.0M | 59.8M | 58.6M | 57.3M |